🇺🇸 Sitagliptin and Gliclazide in United States

Sitagliptin and Gliclazide (Sitagliptin and Gliclazide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Sitagliptin and Gliclazide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Sitagliptin and Gliclazide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sitagliptin and Gliclazide in United States?

Zhibin Xu is the originator. The local marketing authorisation holder may differ — check the official source linked above.